Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Week in Review

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Week in Review: Betta Pharma Enters $392 Million Deal for C4 Therapeutics’ NSCLC Drug

Week in Review: Allgenesis Posts Positive Data from US Trial of Bi-Specific for Diabetic Macular Edema

Week in Review: LaNova Sells Pre-Clinical ADC to AstraZeneca in $600 Million Deal

Week in Review: BlissBio Announces Potential $2 Billion Deal with Eisai for HER2 ADC

Week in Review: Pfizer Picks Sinopharm to Market 12 of its Novel Drugs

ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China